000 01483 a2200409 4500
005 20250514003219.0
264 0 _c20010816
008 200108s 0 0 eng d
022 _a0015-0282
024 7 _a10.1016/s0015-0282(01)01834-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLüdicke, F
245 0 0 _aEffect of a combined oral contraceptive containing 3 mg of drospirenone and 30 microg of ethinyl estradiol on the human endometrium.
_h[electronic resource]
260 _bFertility and sterility
_cJul 2001
300 _a102-7 p.
_bdigital
500 _aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAndrostenes
_xadverse effects
650 0 4 _aAtrophy
650 0 4 _aCell Division
_xdrug effects
650 0 4 _aContraceptives, Oral
_xadverse effects
650 0 4 _aDrug Combinations
650 0 4 _aEndometrium
_xdiagnostic imaging
650 0 4 _aEstradiol Congeners
_xadverse effects
650 0 4 _aEthinyl Estradiol
_xadverse effects
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aProgesterone Congeners
_xadverse effects
650 0 4 _aUltrasonography
700 1 _aJohannisson, E
700 1 _aHelmerhorst, F M
700 1 _aCampana, A
700 1 _aFoidart, J
700 1 _aHeithecker, R
773 0 _tFertility and sterility
_gvol. 76
_gno. 1
_gp. 102-7
856 4 0 _uhttps://doi.org/10.1016/s0015-0282(01)01834-9
_zAvailable from publisher's website
999 _c11367290
_d11367290